Aaron Potretzke, MD
Urology · Rochester, MNNPI 1114157609
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,354 of the $4,542 with a category attached, or 73.8%. Intuitive Surgical accounts for 64.7% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $2,106, more than ten times the $163 reported in 2019.
Across 42 payments — averaging $108.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$3K
- Boston Scientific$885
- Medtronic$319
- Richard Wolf Medical Instruments Corp.$146
- KARL Storz Endoscopy-america$80
- Axonics, Inc.$71
- plus $103 from 2 others
What the payments were for
- Travel & lodging$1,17426%
- Food & beverage$3,35474%
- Gifts$150%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 20 | $2,939 |
| Boston Scientific | 11 | $885 |
| Medtronic | 5 | $319 |
| Richard Wolf Medical Instruments Corp. | 1 | $146 |
| KARL Storz Endoscopy-america | 2 | $80 |
| Axonics, Inc. | 1 | $71 |
| Procept Biorobotics Corporation | 1 | $59 |
| Calyxo, Inc. | 1 | $44 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$2,479
- LithoVue$215
- Tria Firm$143
- LITHOCLAST$107
How this compares
$4,542 in reported general payments places this provider in the 80th percentile of 247 urology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trospium Chloride | 34 | $1,695 |
| Trospium Chloride ErTrospium Chloride | 11 | $1,238 |
| Tamsulosin Hcl | 76 | $757 |
| Cefdinir | 23 | $526 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 29 | $24 |
Paid to pharmacies, not to this prescriber.
Other urology in Rochester
- Jonathan WarnerRochester$144K
- Tobias KohlerRochester$89K
- Stephen BoorjianRochester$61K
- Robert KarnesRochester$29K
- Kevin WymerRochester$16K
- Paras ShahRochester$14K
- Matthew ZiegelmannRochester$9K
- Meghan CooperRochester$8K
- Sevann HeloRochester$6K
- Brian LinderRochester$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.